{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T22:49:52Z","timestamp":1778107792098,"version":"3.51.4"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3S","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Ann Plast Surg"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Diabetic foot ulcer (DFU) is one of the most dreaded complications of diabetes mellitus and is associated with a high risk of lower limb amputation and mortality. Because the efficacy of conventional treatments for DFUs is often limited, regenerative medicine therapy, such as growth factors and stem cells, may provide a solution to chronic wound healing. In this study, we compared several kinds of regenerative therapy for treating DFUs in terms of efficacy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We systemically searched relevant studies on PubMed, Cochrane Library, and EMBASE. Randomized clinical trials on conventional treatment combined with platelet-rich plasma (PRP), epidermal growth factor (EGF), or stem cell therapy, compared with conventional treatment alone in patients with DFUs, were included in this study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 1454 patients from 23 randomized controlled trials (RCTs) were included in the network meta-analysis. In terms of the number of completely healed ulcers, no significant difference was noted between PRP, stem cell therapy, and EGF group. We also performed surface under the cumulative ranking curve analyses to predict the rank of each intervention by the number of completely healed ulcers. The predicted ranking was as follows: stem cell, PRP, EGF, and the control group (conventional treatment alone). Furthermore, when we compared the mean of the wound healing time of DFUs among these four interventions, we found that the PRP group achieved significantly earlier ulcer healing than the stem cell, EGF, and control groups. No significant difference was observed in the time needed for wound healing between the stem cell and EGF groups. Funnel plot analysis demonstrated no publication bias.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>PRP combined with conventional treatment significantly accelerates wound healing for DFUs. The mean wound healing time was similar between the stem cell and EGF groups. However, additional reviews of rigorous, large, well-designed RCTs are warranted for further validation of our findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sap.0000000000004192","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T13:04:01Z","timestamp":1740488641000},"page":"S24-S32","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Comparative Efficacy of Regenerative Therapies for Diabetic Foot Ulcers"],"prefix":"10.1097","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6879-4685","authenticated-orcid":false,"given":"Hsi-An","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren-Jun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wun-Long","family":"Jheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Ju","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Jr","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, China Medical University Hospital, Taichung City, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20250228","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/wrr.12554","article-title":"Failure rates of artificial dermis products in treatment of diabetic foot ulcer: a systematic review and network meta-analysis","volume":"25","year":"2017","journal-title":"Wound Repair Regen"},{"key":"bib2-20250228","first-page":"2923759","article-title":"Diabetic foot ulcers and epidermal growth factor: revisiting the local delivery route for a successful outcome","volume":"2017","year":"2017","journal-title":"Biomed Res Int"},{"key":"bib3-20250228","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/wound.2023.0024","article-title":"Advanced biomaterials and topical medications for treating diabetic foot ulcers: a systematic review and network meta-analysis","volume":"13","year":"2024","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"bib4-20250228","doi-asserted-by":"crossref","first-page":"812262","DOI":"10.3389\/fcell.2022.812262","article-title":"Stem cell\u2013based therapy for diabetic foot ulcers","volume":"10","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"bib5-20250228","doi-asserted-by":"crossref","first-page":"869408","DOI":"10.3389\/fbioe.2022.869408","article-title":"Innovative cell and platelet rich plasma therapies for diabetic foot ulcer treatment: the allogeneic approach","volume":"10","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"bib6-20250228","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1089\/ten.tea.2010.0729","article-title":"Platelet lysate induces in vitro wound healing of human keratinocytes associated with a strong proinflammatory response","volume":"17","year":"2011","journal-title":"Tissue Eng Part A"},{"key":"bib7-20250228","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.biologicals.2011.01.002","article-title":"Treatment of recalcitrant ulcers with allogeneic platelet gel from pooled platelets in aged hypomobile patients","volume":"39","year":"2011","journal-title":"Biologicals"},{"key":"bib8-20250228","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrrheum.2013.141","article-title":"Platelet-rich plasma for managing pain and inflammation in osteoarthritis","volume":"9","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"bib9-20250228","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.blre.2013.02.001","article-title":"Blood-derived biomaterials and platelet growth factors in regenerative medicine","volume":"27","year":"2013","journal-title":"Blood Rev"},{"key":"bib10-20250228","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1089\/scd.2013.0567","article-title":"Mesenchymal stem cell paracrine activity is modulated by platelet lysate: induction of an inflammatory response and secretion of factors maintaining macrophages in a proinflammatory phenotype","volume":"23","year":"2014","journal-title":"Stem Cells Dev"},{"key":"bib11-20250228","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.dsx.2017.09.007","article-title":"Platelet rich plasma and growth factors cocktails for diabetic foot ulcers treatment: state of art developments and future prospects","volume":"12","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"bib12-20250228","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11739-016-1583-7","article-title":"Network meta-analysis: an introduction for clinicians","volume":"12","year":"2017","journal-title":"Intern Emerg Med"},{"key":"bib13-20250228","first-page":"l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","year":"2019","journal-title":"BMJ"},{"key":"bib14-20250228","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jrsm.1373","article-title":"MetaInsight: an interactive web-based tool for analyzing, interrogating, and visualizing network meta-analyses using R-shiny and netmeta","volume":"10","year":"2019","journal-title":"Res Synth Methods"},{"key":"bib16-20250228","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.avsg.2016.04.023","article-title":"Platelet-rich plasma for the treatment of clean diabetic foot ulcers","volume":"38","year":"2017","journal-title":"Ann Vasc Surg"},{"key":"bib17-20250228","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2337\/db18-0699","article-title":"Potential of allogeneic adipose-derived stem cell-hydrogel complex for treating diabetic foot ulcers","volume":"68","year":"2019","journal-title":"Diabetes"},{"key":"bib18-20250228","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.avsg.2021.10.061","article-title":"Autologous platelet rich plasma promotes the healing of non-ischemic diabetic foot ulcers. A randomized controlled trial","volume":"82","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"bib19-20250228","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diabres.2018.06.002","article-title":"Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: a phase III multicenter, double-blind, randomized, placebo-controlled trial","volume":"142","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"bib20-20250228","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jss.2019.09.069","article-title":"Autologous platelet-rich gel for the treatment of diabetic sinus tract wounds: a clinical study","volume":"247","year":"2020","journal-title":"J Surg Res"},{"key":"bib21-20250228","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s00268-019-05316-0","article-title":"Randomized controlled trial on autologous platelet-rich plasma versus saline dressing in treatment of non-healing diabetic foot ulcers","volume":"44","year":"2020","journal-title":"World J Surg"},{"key":"bib22-20250228","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0976-9668.136160","article-title":"Efficacy of topical application of beta urogastrone (recombinant human epidermal growth factor) in Wagner's grade 1 and 2 diabetic foot ulcers: comparative analysis of 50 patients","volume":"5","year":"2014","journal-title":"J Nat Sci Biol Med"},{"key":"bib23-20250228","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/wrr.12187","article-title":"Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: a randomized double-blinded controlled trial","volume":"22","year":"2014","journal-title":"Wound Repair Regen"},{"key":"bib24-20250228","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1534734619892791","article-title":"Efficacy of recombinant human epidermal growth factor (Regen-D 150) in healing diabetic foot ulcers: a hospital-based randomized controlled trial","volume":"19","year":"2020","journal-title":"Int J Low Extrem Wounds"},{"key":"bib25-20250228","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1742-481X.2009.00641.x","article-title":"Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study","volume":"6","year":"2009","journal-title":"Int Wound J"},{"key":"bib26-20250228","first-page":"68","article-title":"A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers","volume":"52","year":"2006","journal-title":"Ostomy Wound Manage"},{"key":"bib27-20250228","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/diacare.28.9.2155","article-title":"Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes","volume":"28","year":"2005","journal-title":"Diabetes Care"},{"key":"bib28-20250228","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","article-title":"Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial","volume":"92","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"bib29-20250228","article-title":"The effect of platelet rich plasma dressing on healing diabetic foot ulcers","volume":"5","year":"2016","journal-title":"Nurs Midwifery Stud"},{"key":"bib30-20250228","first-page":"759","article-title":"Efficacy of topical epidermal growth factor in healing diabetic foot ulcers","volume":"2","year":"2005","journal-title":"Clin Pract (London, England)"},{"key":"bib31-20250228","first-page":"PC17","article-title":"Comparison of the efficacy of autologous platelet-rich plasma and saline dressing in healing of diabetic foot ulcer \u2014 a randomised control study","volume":"17","year":"2023","journal-title":"J Clin Diagn Res"},{"key":"bib32-20250228","article-title":"Convectional dressing versus platelet rich plasma in the management of diabetic foot ulcers \u2014 a prospective comparative study","volume":"14","year":"2022","journal-title":"Int J Pharm Clin Res"},{"key":"bib33-20250228","article-title":"Efficacy of platelet rich plasma dressing versus Normal saline dressing in the management of diabetic foot ulcers","volume":"15","year":"2023","journal-title":"Int J Pharm Clin Res"},{"key":"bib34-20250228","doi-asserted-by":"crossref","first-page":"888809","DOI":"10.3389\/fendo.2022.888809","article-title":"Comparison of the impact of autologous cell therapy and conservative standard treatment on tissue oxygen supply and course of the diabetic foot in patients with chronic limb-threatening ischemia: a randomized controlled trial","volume":"13","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"bib35-20250228","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.dsx.2021.03.005","article-title":"Evaluation of the efficacy of platelet-rich plasma on healing of clean diabetic foot ulcers: a randomized clinical trial in Tehran, Iran","volume":"15","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"bib36-20250228","first-page":"5365","article-title":"Experimental study of epidermal growth factor and acidic fibroblast growth factor in the treatment of diabetic foot wounds","volume":"15","year":"2018","journal-title":"Exp Ther Med"},{"key":"bib37-20250228","doi-asserted-by":"crossref","first-page":"627098","DOI":"10.3389\/fphar.2021.627098","article-title":"Therapeutic effect of epidermal growth factor combined with nano silver dressing on diabetic foot patients","volume":"12","year":"2021","journal-title":"Front Pharmacol"},{"key":"bib38-20250228","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.fas.2020.08.002","article-title":"Intralesional allogeneic adipose-derived stem cells application in chronic diabetic foot ulcer: phase I\/2 safety study","volume":"27","year":"2021","journal-title":"Foot Ankle Surg"},{"key":"bib39-20250228","first-page":"e20190070","article-title":"WIfI classification: the Society for Vascular Surgery lower extremity threatened limb classification system, a literature review","volume":"19","year":"2020","journal-title":"J Vasc Bras"},{"key":"bib40-20250228","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.semvascsurg.2022.04.002","article-title":"Management of the diabetic foot","volume":"35","year":"2022","journal-title":"Semin Vasc Surg"},{"key":"bib41-20250228","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.4239\/wjd.v13.i12.1014","article-title":"Diabetic foot ulcer: challenges and future","volume":"13","year":"2022","journal-title":"World J Diabetes"},{"key":"bib42-20250228","doi-asserted-by":"crossref","first-page":"12","DOI":"10.52547\/wjps.11.1.12","article-title":"Mesenchymal stem cells regenerate diabetic foot ulcers: a review article","volume":"11","year":"2022","journal-title":"World J Plast Surg"},{"key":"bib43-20250228","doi-asserted-by":"crossref","first-page":"1480249","DOI":"10.1080\/2000625X.2018.1480249","article-title":"Cost-effectiveness analysis of the human recombinant epidermal growth factor in the management of patients with diabetic foot ulcers","volume":"9","year":"2018","journal-title":"Diabet Foot Ankle"},{"key":"bib44-20250228","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.avsg.2023.05.045","article-title":"Efficacy of platelet-rich plasma in the treatment of diabetic foot ulcers: a systematic review and meta-analysis","volume":"98","year":"2024","journal-title":"Ann Vasc Surg"},{"key":"bib46-20250228","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s13018-023-03854-x","article-title":"Efficacy and safety of autologous platelet-rich plasma for diabetic foot ulcer healing: a systematic review and meta-analysis of randomized controlled trials","volume":"18","year":"2023","journal-title":"J Orthop Surg Res"},{"key":"bib47-20250228","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/IDR.S186651","article-title":"Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds","volume":"12","year":"2019","journal-title":"Infect Drug Resist"},{"key":"bib48-20250228","first-page":"e43452","article-title":"The use of platelet-rich plasma in the treatment of diabetic foot ulcers: a scoping review","volume":"15","year":"2023","journal-title":"Cureus"},{"key":"bib49-20250228","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jcyt.2014.06.003","article-title":"Platelet-rich plasma affects bacterial growth in vitro","volume":"16","year":"2014","journal-title":"Cytotherapy"},{"key":"bib50-20250228","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7150\/thno.16803","article-title":"Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model","volume":"7","year":"2017","journal-title":"Theranostics"},{"key":"bib51-20250228","first-page":"13261","article-title":"The role of gel wound dressings loaded with stem cells in the treatment of diabetic foot ulcers","volume":"13","year":"2021","journal-title":"Am J Transl Res"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000004192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T15:05:03Z","timestamp":1740755103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000004192"}},"subtitle":["A Network Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":49,"journal-issue":{"issue":"3S","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000004192","relation":{},"ISSN":["1536-3708","0148-7043"],"issn-type":[{"value":"1536-3708","type":"electronic"},{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}